Skip to main content
Search

Bruno E. Correia

2 related articles

Subscribe to updates
  1. bioRxiv

    Proteins no longer fold one way: after terminal remodeling, two or three mutations shift the conformational balance

    Protein design has long targeted a single static structure, while natural metamorphic proteins occupy multiple folded states under the same conditions. Using RFdiffusion to partially remodel the termini of 93 native domains yielded 2,291 native-alternative conformation pairs; two sequence-design routes then made one sequence compatible with both backbones, and AlphaFold3 with BioEmu selected state-stabilizing mutations. The designs showed broadened and missing NMR crosspeaks, indicating microsecond-to-millisecond exchange in the metamorphic region; two or three mutations shifted the equilibrium toward either state, yielding crystal and NMR structures consistent with the design models.

  2. bioRxiv

    LDDM: A Unified 3D Generative Model for Synthesizable Structure-Based Drug Design

    The work introduces LDDM (Large Drug Discovery Model), a unified 3D generative framework supporting constrained and unconstrained docking, fragment linking and growing, and de novo design, together with a programmable design algorithm that produces synthetically accessible compounds satisfying fine-grained objectives; the authors experimentally validated designed or optimised ligands for five therapeutically relevant protein targets, achieving high success rates and identifying molecules with confirmed binding affinity while synthesizing only a small number of generated compounds, with the best designs structurally characterised by NMR spectroscopy and X-ray crystallography indicating high prediction accuracy.

You’re all caught up